Safety evaluation of oral calcitonin-gene–related peptide receptor antagonists in patients with acute migraine: a systematic review and meta-analysis.

MLA

Lee, Seoyeon, et al. “Safety Evaluation of Oral Calcitonin-Gene–related Peptide Receptor Antagonists in Patients with Acute Migraine: A Systematic Review and Meta-Analysis.” European Journal of Clinical Pharmacology, vol. 78, no. 9, Sept. 2022, pp. 1365–76. EBSCOhost, https://doi.org/10.1007/s00228-022-03347-6.

APA

Lee, S., Staatz, C. E., Han, N., & Baek, I. (2022). Safety evaluation of oral calcitonin-gene–related peptide receptor antagonists in patients with acute migraine: a systematic review and meta-analysis. European Journal of Clinical Pharmacology, 78(9), 1365–1376. https://doi.org/10.1007/s00228-022-03347-6

Chicago

Lee, Seoyeon, Christine E. Staatz, Nayoung Han, and In-hwan Baek. 2022. “Safety Evaluation of Oral Calcitonin-Gene–related Peptide Receptor Antagonists in Patients with Acute Migraine: A Systematic Review and Meta-Analysis.” European Journal of Clinical Pharmacology 78 (9): 1365–76. doi:10.1007/s00228-022-03347-6.